QuidelOrtho Corporation (0A55.L)

Name: QuidelOrtho Corporation Financial Statements
Creator: Quarter Results

Healthcare | Medical Specialties

Latest reporting period: 2025-09-28

Latest Quarter

2025-09-28

Revenue

$700M

Net Income

-$733M

Operating Margin

-100.7%

Free Cash Flow

-$112M

Debt / Assets

57.2%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for QuidelOrtho Corporation (0A55.L).
Income Statement (Quarterly)	2025-09-28	2025-06-29	2025-03-30	2024-12-31
Revenue	699,900,000	615,100,000	692,800,000	707,800,000
Cost of Revenue	47,700,000	386,800,000	349,500,000	381,700,000
Gross Profit	652,200,000	228,300,000	343,300,000	326,100,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	186,900,000	178,000,000	187,000,000	187,500,000
Operating Expenses	1,357,000,000	228,800,000	310,700,000	426,500,000
Operating Income	-704,800,000	-500,000	32,600,000	-100,400,000
Interest Expense	46,100,000	46,100,000	42,300,000	44,700,000
Income Before Tax	-756,900,000	-229,600,000	-8,800,000	-140,900,000
Income Tax Expense	-23,900,000	25,800,000	3,900,000	37,500,000
Net Income	-733,000,000	-255,400,000	-12,700,000	-178,400,000
Per Share
EPS	-10.78	-3.77	-0.19	-2.28
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for QuidelOrtho Corporation (0A55.L).
Income Statement (Annual)	2024-12-31	2024-12-29	2023-12-31	2023-01-01
Revenue	2,782,900,000	2,782,900,000	2,997,800,000	3,263,100,000
Cost of Revenue	1,496,400,000	1,496,400,000	1,503,400,000	1,613,000,000
Gross Profit	1,286,500,000	1,286,500,000	1,494,400,000	1,650,100,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	766,800,000	766,800,000	763,200,000	621,000,000
Operating Expenses	3,247,400,000	3,247,400,000	1,355,300,000	672,700,000
Operating Income	-1,960,900,000	-1,960,900,000	139,100,000	977,400,000
Interest Expense	188,300,000	188,300,000	178,900,000	74,000,000
Income Before Tax	-2,131,500,000	-2,131,500,000	-29,100,000	735,900,000
Income Tax Expense	-79,500,000	-79,500,000	-19,000,000	187,200,000
Net Income	-2,052,000,000	-2,052,000,000	-10,100,000	548,700,000
Per Share
EPS	-30.54	-30.54	-0.15	9.66
EPS Diluted	0.00	0.00	0.00	0.00

Balance sheet quarterly history for QuidelOrtho Corporation (0A55.L).
Balance Sheet (Quarterly)	2024-12-31	2024-12-29	2023-12-31	2023-01-01
Assets
Cash and Cash Equivalents	98,300,000	98,300,000	118,900,000	292,900,000
Short Term Investments	0	0	48,400,000	52,100,000
Net Receivables	451,300,000	451,300,000	488,400,000	586,400,000
Inventory	533,700,000	533,700,000	577,800,000	524,100,000
Total Current Assets	1,218,900,000	1,218,900,000	1,310,500,000	1,575,100,000
Property Plant Equipment	1,548,900,000	1,548,900,000	1,613,400,000	1,520,000,000
Goodwill and Intangibles	3,385,100,000	3,385,100,000	5,426,300,000	5,600,600,000
Total Assets	6,967,800,000	6,423,600,000	8,563,100,000	8,855,800,000
Liabilities
Account Payables	246,000,000	246,000,000	294,800,000	283,300,000
Short Term Debt	404,000,000	372,900,000	166,500,000	231,900,000
Total Current Liabilities	998,800,000	998,800,000	833,800,000	1,007,000,000
Long Term Debt	2,308,500,000	2,308,500,000	2,447,600,000	2,430,000,000
Total Liabilities	3,983,300,000	3,439,100,000	3,557,200,000	3,921,200,000
Shareholders Equity
Retained Earnings	135,800,000	135,800,000	2,187,800,000	2,197,900,000
Total Shareholders Equity	2,984,500,000	2,984,500,000	5,005,900,000	4,934,600,000

Balance sheet annual history for QuidelOrtho Corporation (0A55.L).
Balance Sheet (Annual)	2024-12-31	2024-12-29	2023-12-31	2023-01-01
Assets
Cash and Cash Equivalents	98,300,000	98,300,000	118,900,000	292,900,000
Short Term Investments	0	0	48,400,000	52,100,000
Net Receivables	451,300,000	451,300,000	488,400,000	586,400,000
Inventory	533,700,000	533,700,000	577,800,000	524,100,000
Total Current Assets	1,218,900,000	1,218,900,000	1,310,500,000	1,575,100,000
Property Plant Equipment	1,548,900,000	1,548,900,000	1,613,400,000	1,520,000,000
Goodwill and Intangibles	3,385,100,000	3,385,100,000	5,426,300,000	5,600,600,000
Total Assets	6,967,800,000	6,423,600,000	8,563,100,000	8,855,800,000
Liabilities
Account Payables	246,000,000	246,000,000	294,800,000	283,300,000
Short Term Debt	404,000,000	372,900,000	166,500,000	231,900,000
Total Current Liabilities	998,800,000	998,800,000	833,800,000	1,007,000,000
Long Term Debt	2,308,500,000	2,308,500,000	2,447,600,000	2,430,000,000
Total Liabilities	3,983,300,000	3,439,100,000	3,557,200,000	3,921,200,000
Shareholders Equity
Retained Earnings	135,800,000	135,800,000	2,187,800,000	2,197,900,000
Total Shareholders Equity	2,984,500,000	2,984,500,000	5,005,900,000	4,934,600,000

Cash flow quarterly history for QuidelOrtho Corporation (0A55.L).
Cash Flow Statement (Quarterly)	2024-12-31	2024-12-29	2023-12-31	2023-01-01
Operating Activities
Net Income	-2,052,000,000	-2,052,000,000	-10,100,000	548,700,000
Depreciation & Amortization	453,400,000	453,400,000	457,200,000	283,600,000
Stock Based Compensation	0	42,100,000	51,600,000	65,599,999
Change in Working Capital	-158,700,000	-158,700,000	-194,900,000	-53,200,000
Operating Cash Flow	83,000,000	83,000,000	280,200,000	885,300,000
Investing Activities
Capital Expenditure	-195,100,000	-195,100,000	-209,300,000	-140,900,000
Investments	-195,100,000	-195,100,000	-209,300,000	-140,900,000
Investing Cash Flow	-149,900,000	-149,900,000	-187,600,000	-1,644,200,000
Financing Activities
Debt Repayment	53,400,000	53,400,000	-226,400,000	-346,200,000
Common Stock Issued/Repurchased	5,000,000	5,000,000	4,400,000	-47,900,000
Dividends Paid	0	0	0	0
Financing Cash Flow	48,800,000	48,800,000	-265,800,000	252,000,000
Summary
Free Cash Flow	-112,100,000	-112,100,000	70,900,000	744,400,000
Net Change in Cash	0	-21,000,000	-174,400,000	-509,851,000

Cash flow annual history for QuidelOrtho Corporation (0A55.L).
Cash Flow Statement (Annual)	2024-12-31	2024-12-29	2023-12-31	2023-01-01
Operating Activities
Net Income	-2,052,000,000	-2,052,000,000	-10,100,000	548,700,000
Depreciation & Amortization	453,400,000	453,400,000	457,200,000	283,600,000
Stock Based Compensation	0	42,100,000	51,600,000	65,599,999
Change in Working Capital	-158,700,000	-158,700,000	-194,900,000	-53,200,000
Operating Cash Flow	83,000,000	83,000,000	280,200,000	885,300,000
Investing Activities
Capital Expenditure	-195,100,000	-195,100,000	-209,300,000	-140,900,000
Investments	-195,100,000	-195,100,000	-209,300,000	-140,900,000
Investing Cash Flow	-149,900,000	-149,900,000	-187,600,000	-1,644,200,000
Financing Activities
Debt Repayment	53,400,000	53,400,000	-226,400,000	-346,200,000
Common Stock Issued/Repurchased	5,000,000	5,000,000	4,400,000	-47,900,000
Dividends Paid	0	0	0	0
Financing Cash Flow	48,800,000	48,800,000	-265,800,000	252,000,000
Summary
Free Cash Flow	-112,100,000	-112,100,000	70,900,000	744,400,000
Net Change in Cash	0	-21,000,000	-174,400,000	-509,851,000